Journal News

A balancing game with implications for neurodegenerative disease

Leia Dwyer
June 8, 2021

Mitochondria in healthy cells have a stable balance of fission and fusion, the processes by which these cellular organelles divide and merge. Mitochondrial DNA is essential for their proper function, and mitochondrial fusion can help overcome genetic malfunctions and recycle proteins of nonfunctioning mitochondria in the cell. While researchers still have many questions about mitochondrial fission and fusion, we know these processes are particularly important in the brain and nerves, and recent studies suggest that mitochondrial fission and fusion are altered in several neurodegenerative diseases including Alzheimer’s.

Mitochondria-445x350.jpg

Ken Nakamura, a professor at the Gladstone Institute of Neurological Disease at the University of California, San Francisco, focuses his research on cellular mitochondrial function and association with neurological disease. In a recent paper in the Journal of Biological Chemistry, Lauren Shields, then a grad student, and a team from the Nakamura lab describe research into how mitochondrial fission is related to the toxicity of a key Alzheimer’s disease protein, amyloid-beta precursor protein, or APP. Shields, who was always interested in the neurosciences field, pushed the lab beyond its previous focus on Parkinson's disease and remembers that she was the "first graduate student to venture into Alzheimer's."

The research focused on understanding the role of dynamin-related protein 1, or Drp1, an essential mitochondrial fission protein that is increased in the brain tissue of Alzheimer’s disease patients and may be associated indirectly with metabolism of the calcium ions, or Ca2+, in the cell.

“Mitochondria are unusual organelles,” Shields said. “This all goes back to the theory of evolution that mitochondria were bacteria-like and were encompassed by cells … they’ve maintained this fission and fusion function.”

The researchers studied mice that were genetically altered to express mutant human APP, known as hAPP mice, with a targeted deletion of Drp1 that prevented fission in mitochondria. They found that the Drp1 knockout intensified the spatial learning and memory impairments observed in the hAPP mice.

Shields and the team also found that the loss of Drp1 combined with mutant hAPP to produce mitochondrial Ca2+ overload, possibly due to excessive influx of Ca2+ from the cytosol into mitochondria. They concluded that mitochondrial fission may be a protective mechanism against mitochondrial Ca2+ overload, which may be an initiating factor in the cascade of toxic insults that combine to cause neuronal dysfunction and degeneration in Alzheimer’s disease.

This work clearly shows the need for the delicate balance of mitochondrial fusion and fission in healthy cells. Because Drp1 is known to be increased in post-mortem Alzheimer’s disease patient tissue, the team originally had hypothesized that Drp1 could be a good therapeutic target. However, they concluded that Drp1 actually would be a risky target, given the need for careful calibration of the fission–fusion balance and Drp1’s protective role in Ca2+ homeostasis.

“A lot of what my time in the neurodegenerative field really underscored for me is how complex humans are, how complex the brain is and how complex neurodegenerative cascades are,” Shields said. “This is one more small piece of that big story.”

Leia Dwyer

Leia Dwyer is a Boston-area biotech and pharmaceutical industry professional.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Can people vaccinated against COVID-19 still spread the coronavirus?
News

Can people vaccinated against COVID-19 still spread the coronavirus?

June 6, 2021

Preliminary evidence seems to suggest that someone who’s vaccinated is less likely transmit the virus, but the proof is not yet ironclad.

Addgene expands its collection into antibodies
News

Addgene expands its collection into antibodies

June 4, 2021

The reagent repository Addgene, known for distribution and quality control of plasmids for open science, is expanding into recombinant antibodies and nanobodies in partnership with NeuroMab.

Study reveals experimental targets for lymphoma research
Journal News

Study reveals experimental targets for lymphoma research

June 3, 2021

An enzyme previously linked to lymphoma development may have more functions than previously thought.

Exploring underappreciated molecules and new cities
Interview

Exploring underappreciated molecules and new cities

June 2, 2021

Neurochemist Xianlin Han has been an associate editor for the Journal of Lipid Research since 2019.

Researchers target cell membrane for cancer research
Journal News

Researchers target cell membrane for cancer research

June 1, 2021

“The central idea is that if you alter the composition of the cell membrane, you can potentially alter the functionality of the proteins within the membrane and thus the disease overall.”

Could the immune system be key to Alzheimer’s disease?
News

Could the immune system be key to Alzheimer’s disease?

May 30, 2021

Increasing evidence suggests that chronic inflammation takes a toll on the brain over the course of a lifetime